Source: MarketScreener

Uromedica: Uromedica Announces New CPT-I codes for ProACT Adjustable Continence Therapy for Men

(marketscreener.com) Uromedica, Inc. announces today that four new Category I CPT codes have been assigned to their FDA-approved product, ProACT Adjustable Continence Therapy for Men and will be effective January 1st, 2022. The new CPT-I codes will be: 53451 , 53452 , 53453 , and 53454 fluid volume). The ProACT Therapy previously received Category III codes...https://www.marketscreener.com/news/latest/Uromedica-Announces-New-CPT-I-codes-for-ProACT-trade-Adjustable-Continence-Therapy-for-Men--37083963/?utm_medium=RSS&utm_content=20211119

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Tim Cook's photo - CEO of Uromedica

CEO

Tim Cook

CEO Approval Rating

86/100

Read more